Monitoring and Assessment Program (MAP)

The COVID-19 Monitoring and Assessment Program (MAP) ended on June 30, 2023 and the last day of operation was June 22.

For questions or to request results until July 31st, email This email is monitored Monday-Friday.

MAP was created in spring 2020 to develop and expand the university’s testing capacity for the coronavirus that causes COVID-19.

The program leveraged the research strengths of the UO, including experts in genomics, data science, prevention science, and other areas.

MAP Tests Provided

MAP Goals

  1. Develop a fully operational clinical laboratory improvement amendments (CLIA)-certified testing laboratory on campus.

  2. Create test collection and test processing systems to provide capacity for screening and surveillance testing for COVID-19 at UO and its surrounding community.

  3. Use the results of the testing to develop strategies that local officials and university leaders can enact to reduce the spread of COVID-19 as activity and population changes occur.

Sample Collection Methods

  • Self-collected saliva—in use
  • Self-collected shallow nasal swab (anterior nares)—in use
  • Deep nasal swab—approved, but not in use

Sample Processing Methods

  • DiaCarta QuantiVirus SARS-CoV-2 quantitative PCR (qPCR) – in use

  • Genotyping by RNA sequencing, and high throughput RNA-seq of entire viral genomes—in use

  • Saliva Direct—in use

  • SwabSeq—optimized but not in use